Evidence map›Paper›PMID 42681055›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Computational Identification and Structural Analysis of Ustilago maydis Effector Proteins.

Max Heinen, Florian Altegoer

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Max HeinenInstitute of Microbiology, Cluster of Excellence on Plant Sciences, Heinrich Heine University, 40225, Düsseldorf, Germany.
Florian AltegoerInstitute of Microbiology, Cluster of Excellence on Plant Sciences, Heinrich Heine University, 40225, Düsseldorf, Germany. altegoer@hhu.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To successfully colonize their hosts, fungi secrete specialized proteins known as effectors that manipulate host physiology, for example, by suppressing immune responses or altering host cellular processes. Effector proteins are central to fungal virulence, yet they frequently lack recognizable domains and show little to no sequence conservation, reflecting their rapid adaptation during host-pathogen coevolution. As a result, annotation is limited and structure-function relationships remain poorly understood. In this study, a systematic computational workflow is presented for the identification and structural analysis of putative effector proteins in Ustilago maydis, a biotrophic model fungus. The protocol begins with retrieval of genome-derived protein sequences, prediction of secretion signals, and conversion of identifiers into standardized formats. Structural models are then obtained from the AlphaFold Protein Structure Database or generated de novo using AlphaFold 3/ColabFold. To facilitate comparative analysis, predicted structures can subsequently be clustered and explored using tools such as FoldMason and Foldseek, enabling inference of potential functional relationships. This approach integrates widely available resources with accessible computational steps, lowering the barrier for researchers without extensive bioinformatics expertise. It provides a framework to prioritize effector candidates for experimental validation and can be readily applied to diverse fungal pathogens.

Indexed as

Computational BiologyFungal ProteinsUstilagoBasidiomycotaDatabases, ProteinHost-Pathogen InteractionsModels, MolecularProtein ConformationSoftwareFungal ProteinsEffector proteinsHost–pathogen interactionsStructural bioinformaticsStructure-based clusteringStructure prediction

Identifiers

PMID42681055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.